Malaria Vaccines Not Needed for India’s Low-Transmission Setting: Experts
12 Aug 2025 4:00 PM IST12 Aug 2025 4:00 PM IST
Minister Anupriya Patel tells Rajya Sabha that vaccines like R21/Matrix-M are intended for regions with higher child mortality risk from malaria.
An expert committee has advised against adopting malaria vaccines in India, citing the country’s low transmission levels and limited child mortality risk from the disease.
An expert committee has recommended that India does not fall within the criteria for adopting malaria vaccines as they are used for moderate to high transmission settings with a risk of deaths in children, Rajya Sabha was informed on Tuesday.Minister of State for Health Anupriya Patel was responding to a question on whether India's first malaria vaccine, R21/Matrix-M, has been co-developed by the University of Oxford and the Serum Institute of India and if the vaccine has received regulatory approval for use in the country.
"The matter for use of Malaria vaccine in context of India has been reviewed in a duly constituted expert committee which recommended that India does not fall within the criteria for adopting Malaria vaccines as the vaccines are used for moderate to high transmission settings with a risk of Malaria deaths in children," she said in a written reply.
( Source : PTI )
Next Story